CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea

Jae Seung Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Jin Sil Seong, Kwang-Hyub Han, Do Young Kim

Clin Mol Hepatol. 2020;26(1):24-32. Published online 2019 May 20 DOI: https://doi.org/10.3350/cmh.2018.0065

A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea

Jae Seung Lee, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Jin Sil Seong, Kwang-Hyub Han, Do Young Kim

Clinical and Molecular Hepatology. 2020;26(1):24-32

Link1

Link2 Link3

Treatment Strategy of Transarterial Chemoembolization for Hepatocellular Carcinoma

Shiro Miyayama

Applied Sciences. 2020;10(20):7337

Link1

Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma

Hwi Young Kim, Joong-Won Park, Jungnam Joo, Se Jin Jung, Sangbu An, Sang Myung Woo, Hyun Beom Kim, Young Hwan Koh, Woo Jin Lee, Chang-Min Kim

Journal of Gastroenterology and Hepatology. 2012;27(6):1051-1056

Link1 Link2

Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study

Tao Ouyang, Junxia Liu, Chengyang Shi, Lisheng Zhu, Xiaopeng Guo

Journal of Hepatocellular Carcinoma. 2021;Volume 8:1459-1471

Link1 Link2

Comparison of treatment response, survival profiles as well as safety profiles between CalliSpheres® microspheres transarterial chemoembolization and conventional transarterial chemoembolization in huge hepatocellular carcinoma

Xuhua Duan, Juanfang Liu, Xinwei Han, Jianzhuang Ren, Hao Li, Fengyao Li, Shuguang Ju

. 2020;

Link1 Link2

Tao Ouyang, Junxia Liu, Chengyang Shi, Lisheng Zhu, Xiaopeng Guo

Journal of Hepatocellular Carcinoma. 2022;Volume 9:27-28

Link1 Link2

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Roman Kloeckner, Arndt Weinmann, Friederike Prinz, Daniel Pinto dos Santos, Christian Ruckes, Christoph Dueber, Michael Bernhard Pitton

BMC Cancer. 2015;15(1):

Link1 Link2

Link3 Link4

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma

Waleed Fateen, Farooq Khan, Richard O’Neill, Martin James, Stephen Ryder, Guruprasad Aithal

Journal of Hepatocellular Carcinoma. 2017;Volume 4:123-130

Link1 Link2

Transarterial Chemoembolization Combined with Iodine 125 Seeds Versus Transarterial Chemoembolization Combined with Radiofrequency Ablation in the Treatment of Early- and Intermediate-stage Hepatocellular Carcinoma

chen lei, Xuefeng Kan, Tao Sun, Yanqiao Ren, Yanyan Cao, Liangliang Yan, Bin Liang, Bin Xiong, Chuansheng Zheng

. 2020;

Link1 Link2

Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality

Do Young Kim, Kwang-Hyub Han

Hepatology International. 2016;10(6):883-892

Link1

Link2 Link3

Link4

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.